packageMecasermin

mecasermin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mecasermin, a recombinant growth factor, is used to treat Laron syndrome, a growth disorder. It is authorised in the European Union and is used only in specialised care, given its rare indication.

Summary written by glm-5.3-flash from Wikidata Q6804390 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mecasermin
ATC codes:H01AC03
DrugBank:DB01277
Wikidata:Q6804390
molar mass:7649 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown